Gelofusine EP 0.070gm/0.038gm/0.85gm Injection
Marketer
B Braun Medical Pvt Ltd
Salt Composition
Calcium Chloride (0.070gm) + Potassium Chloride (0.038gm) + Sodium Chloride (0.85gm)
Overview Gelofusine EP 0.070gm/0.038gm/0.85gm Injection
Haes-steril, a three-component intravenous solution (0.070gm/0.038gm/0.85gm), provides short-term fluid resuscitation following injury. It replenishes bodily fluids and electrolytes. Administration must be supervised by a medical professional; self-injection is strictly prohibited. Minor injection site reactions, including redness, pain, or swelling, may occur. Persistent reactions warrant medical attention. Prior to use, disclose all pre-existing health issues, concurrent medications, and pregnancy/breastfeeding status to your physician. Alcohol consumption post-administration is discouraged.
Uses of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection
Post-trauma hydration management
Major Benefits of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection:
- Injection site reactions (pain, swelling, redness)
How to use Gelofusine EP 0.070gm/0.038gm/0.85gm Injection:
Administering this medication will be handled by your physician or their qualified assistant; self-medication is strictly prohibited.
How Gelofusine EP 0.070gm/0.038gm/0.85gm Injection works:
A balanced solution of calcium chloride, potassium chloride, and sodium chloride, Gelofusine EP (0.070gm/0.038gm/0.85gm) injection, restores essential electrolytes and fluids. Its therapeutic action addresses dehydration resulting from traumatic injury.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Gelofusine EP 0.070gm/0.038gm/0.85gm Injection is uncertain. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection with breastfeeding are lacking. Seek medical advice from your physician.
DrivingNOT RELEVANT
Irrelevant, given that Gelofusine EP 0.070gm/0.038gm/0.85gm Injection is administered solely within a hospital setting.
KidneyCAUTION
Exercise caution when administering Gelofusine EP 0.070gm/0.038gm/0.85gm Injection to individuals with advanced renal impairment. Dosage modification of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, professional medical advice is recommended.
What if you forget to take Gelofusine EP 0.070gm/0.038gm/0.85gm Injection :
Should you have omitted a scheduled dose of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection, seek medical advice.
Facts to Know About Gelofusine EP 0.070gm/0.038gm/0.85gm Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Eye medication. |
3,018 People bought this recently